ABBV vs NBIX
AbbVie vs Neurocrine Biosciences — AI-powered side-by-side comparison
| Metric | ABBV | NBIX |
|---|---|---|
| AI Score | 52 | 70 |
| Price | $243.70 | $166.11 |
| P/E Ratio | 69.05× | 23.58× |
| ROE | -129.2% | 14.7% |
| Revenue Growth YoY | — | — |
| Gross Margin | 74.1% | 98.0% |
| Debt / Equity | 2.47× | 0.11× |
| Dividend Yield | 2.8% | 0.0% |
| RSI (14) | 33.5 | 36.1 |
| Beta | 0.28 | 0.386 |
| Expected Upside | — | — |
Want the full breakdown?
Committee votes, technicals, and trade plans for both companies.
ABBV Full Analysis
NBIX Full Analysis